SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027576
Filing Date
2021-05-13
Accepted
2021-05-13 16:21:39
Documents
86
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fdmt-10q_20210331.htm   iXBRL 10-Q 2383461
2 EX-31.1 fdmt-ex311_29.htm EX-31.1 20194
3 EX-31.2 fdmt-ex312_26.htm EX-31.2 20250
4 EX-32.1 fdmt-ex321_27.htm EX-32.1 10234
  Complete submission text file 0001564590-21-027576.txt   8514260

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA fdmt-20210331.xsd EX-101.SCH 72932
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fdmt-20210331_cal.xml EX-101.CAL 36026
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fdmt-20210331_def.xml EX-101.DEF 253063
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE fdmt-20210331_lab.xml EX-101.LAB 474603
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fdmt-20210331_pre.xml EX-101.PRE 398937
10 EXTRACTED XBRL INSTANCE DOCUMENT fdmt-10q_20210331_htm.xml XML 1388485
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39782 | Film No.: 21919966
SIC: 2836 Biological Products, (No Diagnostic Substances)